The Pandemic’s Continued Strain On Labor And Other Key Takeaways From The Diversion Trends Report
The Pandemic’s Continued Strain On Labor And Other Key Takeaways From The Diversion Trends Report
Kit Check recently released its 2022 Diversion Trends Report. In the report, Kit Check analyzed…
KitCheck™ Releases New Medication Pricing Information Function as First Step Towards Further Product Integration.
By Hannah Kanfer KitCheck recently released a new feature that integrates medication pricing information into…
New Bill Will Help Prevent Opioid Deaths by Making Opioid Overdose Medications More Accessible.
By Hannah Kanfer The opioid epidemic has been a long battle in the United…
Early Recognition and Culture of Safety, both Vital to Catching and Preventing Diversion.
Bluesight’s top takeaways from NADDI 2022. By Hannah Kanfer This past week, BluesightⓇ attended the…
The Evolution of 340B and the Challenges it Faces; is Technology the Answer?
The Evolution of 340B and the Challenges it Faces; is Technology the Answer? By Hannah…
Kit Check RFID Helps Reading Hospital with its COVID-19 Vaccine Roll Out
While the newly FDA approved COVID-19 vaccines from Pfizer and Moderna are a welcome reprieve …
Seeing More, Achieving More with Bluesight
Has your team outgrown your current tools and software in the hospital pharmacy? It’s time …
Diversion Quarterly — Q3 2020
Kit Check is sharing data from its Bluesight™ for Controlled Substances platform on a quarterly…
Introducing Beju Shah, Kit Check’s New Director of Clinical Solutions
Beju’s career thus far has provided him a unique set of skills – he’s equipped…
DoseID in Healthcare Tech Outlook
Kit Check is a founding member of DoseID, the pharmaceutical industry’s first consortium around best…